Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127435121 | 12743512 | 1 | I | 20160904 | 20160914 | 20160914 | EXP | PL-TEVA-692043ISR | TEVA | WORON J,LEPPERT W,WORDLICZEK J,DOBROGOWSKI J. ADVERSE DRUG INTERACTION IN PATIENTS TREATED FOR PAIN NOT ASSOCIATED WITH CANCER. BOL. 2016 JAN 01;2:16-23. | 0.00 | Y | 0.00000 | 20160914 | MD | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127435121 | 12743512 | 1 | PS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | U | 76999 | |||||||||||
| 127435121 | 12743512 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127435121 | 12743512 | 2 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127435121 | 12743512 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127435121 | 12743512 | Drug interaction | |
| 127435121 | 12743512 | Epistaxis | |
| 127435121 | 12743512 | Gastrointestinal haemorrhage | |
| 127435121 | 12743512 | Gingival bleeding | |
| 127435121 | 12743512 | Vaginal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |